Significant data indicate that Lecanemab , a cutting-edge therapeutic , has the potential to reduce the advance of mild dementia . This therapy focuses on clearing amyloid plaques from the https://bookmarks-hit.com/story25442408/nadecenemab-an-promising-new-dementia-therapy